Crossmark

Metabolism of human pluripotent stem cells and differentiated cells for regenerative therapy: a focus on cardiomyocytes

Published Online: 2021-02-01

Published Print: 2021-12

Authors

Tanosaki, Sho

Tohyama, Shugo https://orcid.org/0000-0002-5898-3543
Kishino, Yoshikazu

Fujita, Jun

Fukuda, Keiichi
License Information

Text and Data Mining valid from 2021-02-01

Version of Record valid from 2021-02-01
More Information

Article History

Received: 26 November 2020

Accepted: 25 January 2021

First Online: 1 February 2021

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: S. Tohyama, J.F., and K.F. own equity in Heartseed, Inc. K.F. is the CEO of Heartseed, Inc. S. Tanosaki has no conflicts of interest to declare.

Document is current